Homeopathy and systematics: a systematic analysis of the therapeutic effects of the plant species used in homeopathy

The therapeutic effects of the plant species used in homeopathy have never been subjected to systematic analysis. A survey of the various Materiae Medicae shows that over 800 plant species are the source of medicines in homeopathy. As these medicines are considered related to one another with respect to their therapeutic effects for treating similar symptoms, the aim is to classify and map them using the concept of homology. This involves placing the discipline of homeopathy into a comparative framework using these plant medicines as taxa, therapeutic effects as characters, and contemporary cladistic techniques to analyse these relationships. The results are compared using cladograms based on different data sets used in biology (e.g. morphological characters and DNA sequences) to test whether similar cladistic patterns exist among these medicines. By classifying the therapeutic actions, genuine homologies can be distinguished from homoplasies. As this is a comparative study it has been necessary first to update the existing nomenclature of the plant species in the homeopathic literature in line with the current International Code of Botanical Nomenclature.

keywords

cladistics - homology - homoplasy - cladograms - nomenclature

• References

• 1 Bharatan V., Humphries C.J., Barnett J.R. Plants names in homeopathy; an annotated checklist of currently accepted names in common use. London: The Natural History Museum; 2002. p. 149.
• 2 Bharatan V., Humphries C.J. Plants names in homeopathy; an annotated checklist of currently accepted names in common use. Homeopathy 2002; 91 (03) 156-161.
• 3 Van Zandvoort R. The complete repertory: mind – generalities. The Netherlands: Institute for Research in Homeopathic Information and Symptomatology; 2000. p. 570.
• 4 Bharatan V, Homeopathy and systematics, Ph.D. thesis, University of Reading, 2003, p. 163 + CD.
• 5 Chase M.W., Soltis D.E., Olmstead R.G. et al. Phylogenetics of seed plants: an analysis of nucleotide sequences from the plastid gene rbcL. Ann Mo Bot Gard 1993; 80: 528-580.
• 6 Kitching I.J., Forey P.L., Humphries C.J. et al. Cladistics: the theory and practice. 2nd edn. Oxford: Oxford University Press; 1998. p. 248.
• 7 Boericke W. Homoeopathic materia medica with repertory. London: Homoeopathic Book Service; 1987. p. 1042.
• 8 Miller R.G. Relationship of remedies. London: Homoeopathic Publishing Co; 1933. p. 32.
• 9 Clarke JH. A dictionary of practical Materia Medica, 3 Vols. New Delhi: 1978.
• 10 Wright-Hubbard E. A brief study course in homeopathy, St Louis: 1977, p. 102.
• 11 Judd W.S., Campbell C.S., Kellogg E.A. et al. Plant systematics: a phylogenetic approach. Sunderland, MA: Sinauer Associates; 1999. p. 464.
• 12 Jeffrey C. Biological nomenclature. Special Topics in Biology. 3rd edn. 1989. London: Edward Arnold; p. 86.
• 13 Davis P.H., Heywood V.H. Principles of angiosperm taxonomy. Edinburgh and London: Oliver and Boyd; 1973. p. 558.
• 14 Nelson G., Patterson C. Cladistics, sociology and success: a comment on Donoghue's critique of David Hull. Biol Philos 1993; 8: 441-443.
• 15 Paterson C. Cladistics. Biologist 1980; 27: 234-239.
• 16 McNeill J., Barrie F.R., Burdet H.M. et al. International Code of Botanical Nomenclature (Vienna Code): adopted by the Seventeenth International Botanical Congress, Vienna, July 2005. Ruggell, Liechtenstein: Gantner Verlag; 2006. p. 568.
• 17 Goldberg A., Robson D. Smalltalk-80: the language and its implementation. Reading, MA: Addison-Wesley; 1983. p. 736.
• 18 Nixon K.C. Winclada (Beta) ver. 0.9.9. Ithaca NY: Nixon; 1999.
• 19 In: Illingworth V. Dictionary of Computing. 4th edn. 1997. Oxford: Oxford University Press.;
• 20 Goloboff P.A. Analyzing large data sets in reasonable times: solutions for composite optima. Cladistics 1999; 15: 415-428.
• 21 Day W.H.E. Computationally difficult parsimony problems in phylogenetic systematics. J Theor Biol 1983; 103: 429-438.
• 22 Graham R.L., Foulds L.R. Unlikelihood that minimal phylogenies for a realistic biological study can be constructed in reasonable computational time. Math Biosci 1982; 60: 133-142.
• 23 Nixon K.C. The Parsimony Ratchet, a new method for rapid parsimony analysis. Cladistics 1999; 15: 407-414.
• 24 Goloboff P.A. NONA (NO NAME), version 2.0 (for Windows). Tucumán, Argentina. Program and manual available at: 1999. <http://www.cladistics.com>.
• 25 Petersen S., Ranger M., Wolstenholme J. Coronary heart disease statistics: heart failure supplement. London: BHF; 2002.
• 26 In: Reynolds J.E.F. Martindale: the Extra Pharmacopoeia. 29th edn. 1989. London: The Pharmaceutical Press; 1896
• 27 Grossmann M. Effects of cardiac glycosides on 24-h ambulatory blood pressure in healthy volunteers and patients with heart failure. Eur J Clin Invest 2001; 31 (Suppl. 2): 26-30.
• 28 Hollman A. Plants and cardiac glycosides. Br Heart J 1985; 54: 258-261.
• 29 Evans W.C. Trease and Evans' pharmacognosy. 15th edn. London and Philadelphia: Bailliere Tindall; 2002. p. 583.
• 30 Bruneton J. Pharmacognosy: phytochemistry, medicinal plants. 2nd edn. Paris: Lavoisier Publishing; 1999. p. 1136.
• 31 Hipsz M., Kowalski J., Strzelecka H. Cardenolide glycosides of Convallaria majalis. II. Assay of convallatoxin and locundioside. Acta Pol Pharm 1975; 32 (06) 695-701.
• 32 Petershofer-Halbmayer H., Kubelka O., Jrentsch J. et al. Isolation of Hordenine (“Cactine”) from Selenicereus grandiflorus (1.) Britt. & Rose and Selenicereus pteranthus (Link & Otto) Britt. & Rose. Sci Pharm 1982; 50: 29-34.
• 33 Wagner H., Seegert K., Gupta M.P. et al. Cardiotonic active principles from Spigelia anthelmia . Planta Med 1986; 5: 378-381.
• 34 Achenbach H., Hubner H., Vierling W. et al. Spiganthine, the cardioactive principle of Spigelia anthelmia . J Nat Prod 1995; 58 (07) 1092-1096.
• 35 Hubner H., Vierling W., Brandt W. et al. Minor constituents of Spigelia anthelmia and their cardiac activities. Phytochemistry 2001; 57 (02) 285-296.
• 36 Knight A.P., Walter R.G. Plants affecting the cardiovascular system. In: Knight A.P., Walter R.G. A Guide to Plant Poisoning of Animals in North America. 2002. Jackson, WY: Teton NewMedia.;
• 37 Mancini S.D., Edwards J.M. Cytotoxic principles from the sap of Kalmia latifolia . J Nat Prod 1979; 42 (05) 483-488.
• 38 U S Food & Drug Administration Center for Food Safety & Applied Nutrition. Kalmia poisoning from food borne pathogenic microorganisms and natural toxins. <http://caltest.nbc.upenn.edu/poison/plants/ppmount.htm>. 1992 (accessed August 03).
• 39 Koike K., Jia Z., Nikaido T.J. New triterpenoid saponins and sapogenins from Saponaria officinalis . J Nat Prod 1999; 62 (12) 1655-1659.
• 40 Angner R.T., Kelly R.M., Wiley R.G. et al. Preferential destruction of cerebellar Purkinje cells by OX7-saporin. Neurotoxicology 2000; 21 (03) 395-403.
• 41 Lacaille-Dubois M.A., Wagner H. Saponins – a review of the biological and pharmacological activities of saponins. Phytomedicine 1996; 2: 363-386.
• 42 Shutler S.M., Bircher G.M., Tredger J.A. et al. The effect of daily baked bean (Phaseolus vulgaris) Consumption on the plasma lipid levels of young, normo-cholesterolaemic men. Br J Nutr 1989; 61 (02) 257-265.
• 43 La Rosa J.C., Hunninghake D., Bush D. The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation 1990; 81: 1721-1733.
• 44 Saller R., Reichling J. Drugs with Iberis amara as a modern phytotherapy to treat chronic functional disorders of the gastrointestinal tract. Forsch Komplementarmed Klass Naturheilkd 2002 Dec9; (Suppl. 1): V-VI.
• 45 Rigelsky J.M., Sweet B.V. Hawthorn: pharmacology and therapeutic uses. Am J Health Syst Pharm 2002; 59 (05) 417-422.
• 46 Fong H.H., Bauman J.L.J. Hawthorn. Cardiovasc Nurs 2002; 16 (04) 1-8.
• 47 Auf'mkolk M., Kohrle J., Gumbinger H. et al. Antihormonal effects of plant extracts: iodothyronine deiodinase of rat liver is inhibited by extracts and secondary metabolites of plants. Horm Metab Res 1984; 16 (04) 188-192.
• 48 Harvey R. Lycopus europaeus L. and Lycopus virginicus L.: a review of scientific research. Br J Phytother 1995/96; 4 (02) 55-65.
• 49 Wilkins J, The vicious circle and the virtuous spiral: the need for a null hypothesis, version of Tuesday, 28 July 1998, <http://www.users.bigpond.com/thewilkins/papers/nullhyp.html> (accessed August 2003).
• 50 Stahlhut R., Park G., Petersen R. et al. The occurrence of the anti-cancer diterpene taxol in Podocarpus gracilior Pilger (Podocarpaceae). Biochem Syst Ecol 1999; 27 (06) 613-622.
• 51 Balick M.J. Ethnobotany, drug development and biodiversity conservation – exploring the linkages. In: Prance G.T., Chadwick D.J., Marsh J. Ethnobotany and the Search for New Drugs, Ciba Foundation Symposium Series 185. 1994. Chichester: John Wiley; 4-24.
• 52 Cox P.A. The ethnobotanical approach to drug discovery: strengths and limitations. In: Prance G.T., Chadwick D.J., Marsh J. Ethnobotany and the Search for New Drugs, Ciba Foundation Symposium Series 185. 1994. Chichester: John Wiley; 25-41.
• 53 Prance G.T. Conclusions. In: Prance G.T., Chadwick D.J., Marsh J. Ethnobotany and the Search for New Drugs, Ciba Foundation Symposium Series 185. 1994. Chichester: John Wiley; 266-268.
• 54 Bodeker G., Hughes M.A. Wound healing, traditional treatments and research policy. In: Prendergast H.D.V., Etkin N.L., Harris D.R. Plants for Food and Medicine. Proceedings of the Joint Conference of the Society for Economic Botany and the International Society for Ethnopharmacology, London 1–6 July 1996. 1998. Kew: Royal Botanic Gardens; 345-359.
• 55 Hahn R. Sickness and healing – an anthropological perspective. Yale University Press; 1996. p. 336.
• 56 Etkin N.L., Johns T. “Pharmafoods” and “Nutraceuticals”: paradigm shifts in biotherapeutics. In: Prendergast H.D.V., Etkin N.L., Harris D.R. Plants for Food and Medicine. Proceedings of the Joint Conference of the Society for Economic Botany and the International Society for Ethnopharmacology, London 1–6 July 1996. 1998. Kew: Royal Botanic Gardens; 3-16.